Over a decade ago, scientists redefined how to study organ development by generating seemingly unremarkable clumps of cells. They dubbed them organoids: organ-like microstructures produced using stem ...
A cancerous tumor is not a single enemy. It is made up of many different cell populations that can behave in very different ways. Among them, even at the time of diagnosis, there may already be cells ...
Automated cell counting options support laboratories with routine viability testing, fluorescence-based analysis and ...
Modern biomedicine increasingly relies on enormous amounts of image data. Although computers can do part of the analysis work, biologists often still need to look through the images themselves. This ...
Students will have to store their personal devices in a secure location. The location will vary, depending on what is available in each building.
A cancerous tumor is not a single enemy. It is made up of many different cell populations that can behave in very different ways.
DNA changes in certain blood cancers may signal progression to acute myeloid leukemia or myelofibrosis years before routine blood tests detect them.
Circadian rhythms are endogenous, approximately 24-hour oscillations that regulate sleep-wake behavior and tissue-specific physiological and cellular processes. 1,2,3 Circadian variations are evident ...
Research shows that where fat is stored impacts cardiometabolic health, with visceral fat (generally around the organs and in ...
UChicago-led research on cells from mice that had been on the International Space Station for more than a month suggests astronaut hearts can withstand longer trips ...
Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, today reported financial results for ...
Cambridge to lead new £20m MRC Hub to transform development of new medicines using stem cells and AI
The Medical Research Council (MRC) has announced a £20 million investment in a new Pre-clinical Translational Models Hub, led by Cambridge, which will transform the development and testing of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results